Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells
- Supplementary File 1:
Supplementary (PDF, 813 KiB)
Munisvaradass, R.; Kumar, S.; Govindasamy, C.; Alnumair, K.S.; Mok, P.L. Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells. Int. J. Mol. Sci. 2017, 18, 1797. https://doi.org/10.3390/ijms18091797
Munisvaradass R, Kumar S, Govindasamy C, Alnumair KS, Mok PL. Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells. International Journal of Molecular Sciences. 2017; 18(9):1797. https://doi.org/10.3390/ijms18091797
Chicago/Turabian StyleMunisvaradass, Rusheni, Suresh Kumar, Chandramohan Govindasamy, Khalid S. Alnumair, and Pooi L. Mok. 2017. "Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells" International Journal of Molecular Sciences 18, no. 9: 1797. https://doi.org/10.3390/ijms18091797